Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.600, 2010-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rufinamide another option in LGS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 567, 2008-01 ,pp. :
Access to resources
Recommend
Is Generic Prescribing Acceptable in Epilepsy?
By Besag F.M.C.
Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. :
ICER estimates submitted to UK NICE suggestive of funding bias?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Causality Assessment of Adverse Effects: When Is Re-Challenge Ethically Acceptable?
By Li Wan Po A.
Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. :
By Deeks Emma D. Scott Lesley J.
CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. :